The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share. The biotechnology company posted ...
News
- Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot
- WTO chief: Vaccine waiver helpful, not key for virus fight
For instance, Germany, a research powerhouse with strong biotech and pharmaceutical sectors, spoke out against waiving the protections. “The main ...
- 5 most popular innovation stories in Houston this week
This week's roundup of Houston innovators includes Daniel Powell of Spark Biomedical, Carrie Colbert of Curate Capital, and Carson Hager of SafeFun. ... their counterparts in Dallas-Fort Worth, San Antonio, and Austin for overuse ...
- StartUPDATES: New developments from healthcare startups
The study is reported in Nature Biomedical Engineering. ... Texas Health Science Center at San Antonio, to address the unmet need for a drug that can ...
- The Latest: Spain relaxes nationwide virus pandemic measures
... it has begun an accelerated authorization process for an experimental coronavirus treatment made by GlaxoSmithKline and Vir BioTechnology.